Stichting Tuberculosis Vaccine Initiative

Stichting Tuberculosis Vaccine Initiative is an organisation in Lelystad, Netherlands that has taken part in 14 EU-funded projects since 2008, receiving €8.3M in EU funding and leading 5 as coordinator.

EU funding received€8.3M
EU projects14
As coordinator5
Running now6
First EU project2008
Latest project2026
CountryNetherlands
EU registration (PIC)998327008
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Stichting Tuberculosis Vaccine Initiative's own share of each project, not the project's full budget.

  • Horizon Europe€3.7M · 5 projects
  • Horizon 2020€2.5M · 2 projects
  • FP7 (2007 to 2013)€2.1M · 6 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

14 EU-funded projects, newest first. Stichting Tuberculosis Vaccine Initiative led 5 of them as coordinator. Each links to the official record.

  • ACTTIVACCoordinator

    A Phase 2a Randomised Clinical Trial to Identify the Optimal Dose of the Thermostable ID93+GLA-SE Tuberculosis Vaccine for Further Clinical Evaluation and Local Manufacture in Africa

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €825ktheir share
  • T5-TBVACPartner

    EVALUATING A MULTI-VALENT AEROSOL BOOSTER TB VACCINE FOR ADOLESCENTS AND YOUNG ADULTS IN DIVERSE AFRICAN SETTINGS: T5 TBVAC

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €669ktheir share
  • MTBVAC-AVANTEPartner

    Advancing a Vaccine for Adolescent/Adult and Neonatal TB Epidemic

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €1.2Mtheir share
  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • ITHEMYCCoordinator

    Novel immunotherapies for tuberculosis and other mycobacterial diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €508ktheir share
  • TBVAC-HORIZONCoordinator

    Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €500ktheir share
  • STriTuVaDPartner

    In Silico Trial for Tuberculosis Vaccine Development

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €66ktheir share
  • TBVAC2020Coordinator

    TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €2.5Mtheir share
  • EURIPREDPartner

    European Research Infrastructures for Poverty Related Diseases

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €367ktheir share
  • ADITECPartner

    Advanced Immunization Technologies

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €193ktheir share
  • NEWTBVACCoordinator

    Discovery and preclinical development of new generation tuberculosis vaccines

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €1.1Mtheir share
  • TRANSVACPartner

    European Network of Vaccine Development and Research

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €85ktheir share
  • INYVAXPartner

    Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €49ktheir share
  • ESI-TBVIPartner

    Establishment, Strategy and Initial activities of the TuBerculosis Vaccine Initiative : Coordination of European efforts with global research initiatives

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €313ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotic resistance
  • antibiotics
  • drug discovery
  • drug resistance
  • employment
  • genetics
  • immunisation
  • immunology
  • immunotherapy
  • infectious diseases
  • malaria
  • multidrug resistance
  • pandemics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime